Get the latest Science News and Discoveries

New Phase 1 data from Memorial Sloan Kettering Cancer Center shows an investigational cancer vaccine may elicit ... - EurekAlert

<p>New data presented today by Memorial Sloan Kettering Cancer Center (MSK) researchers show an experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based therapeutic cancer vaccine candidate, autogene cevumeran, continues to show potential to stimulate an immune response that may reduce the risk of the disease returning after surgery.</p>

None

Get the Android app